University of Tsukuba Hospital
Ibaraki, Japan
University hospital in Tsukuba
〒305-8576 Ibaraki, Tsukuba, Amakubo, 2 Chome−１−1
About University of Tsukuba Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
9
Eli Lilly and Company
5
Janssen Research & Development, LLC
4
Actelion
3
AstraZeneca
2
Biogen
2
Janssen Pharmaceutical K.K.
2
Pfizer
2
Shire
2
Arcagy Research
1
Boston Scientific Corporation
1
Clinical Trials at University of Tsukuba Hospital
During the past decade, University of Tsukuba Hospital conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 13 clinical trials were completed, i.e. on
average, 38.2% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 8 clinical trials were completed. i.e. 47.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus
2007-07-01
2011-01-01
Completed
25
Study Of AG-013736 (Axitinib) As Second-Line Treatment In Patients With Metastatic Renal Cell Cancer (mRCC)
2007-12-12
2012-10-30
Completed
64
Long-Term, Open-Label Study Of CP-690,550 For Treatment Of Rheumatoid Arthritis In Japan
2008-04-01
2013-12-01
Completed
487
Clinical Study to Investigate the Efficacy and the Safety of DA-9501 in Sedation During the Surgery or Medical Procedure Without Intubation
2011-07-01
2012-03-01
Completed
162
Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial
2010-05-01
2021-02-28
Completed
655
Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies
2012-06-17
2016-05-23
Completed
800
Renal Denervation by MDT-2211 System in Patients With Uncontrolled Hypertension
2012-07-01
2017-06-01
Completed
41
An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)
2013-03-28
2018-09-04
Completed
225
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "University of Tsukuba Hospital" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Eli Lilly and Company" with 5 trials
sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored, "Actelion" with 3 trials sponsored and "AstraZeneca"
with 3 trials sponsored. Other sponsors include 19 different institutions and
companies that sponsored additional 25 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Tsukuba Hospital"
#1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator and "Arbeitsgemeinschaft Gynaekologishe Onkologie Germany" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were
collaborators in the rest 27 trials.
Clinical Trials Conditions at University of Tsukuba Hospital
According to Clinical.Site data, the most researched conditions in "University of Tsukuba Hospital" are
"Breast Neoplasms" (3 trials), "Rheumatoid Arthritis" (3 trials), "Carcinoma, Renal Cell" (2 trials), "Epithelial Ovarian Cancer" (2 trials) and "Paroxysmal Nocturnal Hemoglobinuria" (2 trials). Many other conditions were trialed in "University of Tsukuba Hospital" in a lesser frequency.
Clinical Trials Intervention Types at University of Tsukuba Hospital
Most popular intervention types in "University of Tsukuba Hospital" are "Drug" (44 trials), "Other" (5 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (16 trials), "Atezolizumab" (6 trials), "Abemaciclib" (3 trials), "Exemestane" (3 trials) and "Crovalimab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at University of Tsukuba Hospital
The vast majority of trials in "University of Tsukuba Hospital" are
41 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at University of Tsukuba Hospital
Currently, there are NaN active trials in "University of Tsukuba Hospital".
undefined are not yet recruiting,
12 are recruiting,
13 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 20 completed trials in University of Tsukuba Hospital,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in University of Tsukuba Hospital, 0 "Phase 1"
clinical trials were conducted, 11 "Phase 2" clinical
trials and 35 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".